PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27624845-3	2016	We investigated the role of farnesyl-bound Gal-1 in the cluster formation by analyzing the structure and properties of Gal-1 bound to farnesyl thiosalicylic acid (FTS), a competitive inhibitor of the binding of H-Ras to Gal-1.	farnesylthiosalicylic acid	134-161	galectin 1	Homo sapiens	119-124	
27624845-3	2016	We investigated the role of farnesyl-bound Gal-1 in the cluster formation by analyzing the structure and properties of Gal-1 bound to farnesyl thiosalicylic acid (FTS), a competitive inhibitor of the binding of H-Ras to Gal-1.	farnesylthiosalicylic acid	134-161	galectin 1	Homo sapiens	119-124	
27624845-3	2016	We investigated the role of farnesyl-bound Gal-1 in the cluster formation by analyzing the structure and properties of Gal-1 bound to farnesyl thiosalicylic acid (FTS), a competitive inhibitor of the binding of H-Ras to Gal-1.	farnesylthiosalicylic acid	163-166	galectin 1	Homo sapiens	43-48	
27624845-3	2016	We investigated the role of farnesyl-bound Gal-1 in the cluster formation by analyzing the structure and properties of Gal-1 bound to farnesyl thiosalicylic acid (FTS), a competitive inhibitor of the binding of H-Ras to Gal-1.	farnesylthiosalicylic acid	163-166	galectin 1	Homo sapiens	119-124	
27624845-3	2016	We investigated the role of farnesyl-bound Gal-1 in the cluster formation by analyzing the structure and properties of Gal-1 bound to farnesyl thiosalicylic acid (FTS), a competitive inhibitor of the binding of H-Ras to Gal-1.	farnesylthiosalicylic acid	163-166	galectin 1	Homo sapiens	119-124	
27624845-6	2016	Large-size clusters were likely formed by the interaction among the hydrophobic sites of Gal-1 in the FTS-bound form.	farnesylthiosalicylic acid	102-105	galectin 1	Homo sapiens	89-94	
16113100-17	2005	In order to abrogate growth factor-induced hypersensitivity, we have utilized a drug, farnesylthiosalicylic acid, which blocks the binding of GTP-Ras to its membrane acceptor protein, galectin 1, and reduces the activation of MAP kinase.	farnesylthiosalicylic acid	86-112	galectin 1	Homo sapiens	184-194	
18637482-17	2008	In order to abrogate growth factor induced hypersensitivity, we have utilized a drug, farnesylthiosalicylic acid, which blocks the binding of GTP-Ras to its membrane acceptor protein, galectin 1 and reduces the activation of MAP kinase.	farnesylthiosalicylic acid	86-112	galectin 1	Homo sapiens	184-194